BANCROFT

INSTITUTIONAL REVIEW BOARD

HUMAN RESEARCH REVIEW APPLICATION

INSTRUCTIONS: Check all appropriate boxes, answer all questions completely, include attachments, and obtain
appropriate signatures. After completing the application, please submit an original signed copy to Tracy Kettering,
Farrington Hall, 425 Kings Highway East, Haddonfield, NJ 08033 and send an electronic version of the completed
original IRB application to [email protected]. NOTE: Applications must be typed. Incomplete and
handwritten applications will be returned. Be sure to make a copy for your files.
Step 1: Determine if the proposed research is subject to IRB review.
All research involving human participants conducted within the Bancroft Organization is subject to IRB review. Some, but
not all, studies that involve human participants are considered research and are subject to IRB review.

Additionally, the Office of Human Research Protections (OHRP), an agency of the federal government, provides decision
tree checklists and other information that is available for the public to review. The decision tree checklist on the OHRP
website can assist you in determining your research is subject to IRB review.

Step 2: If the proposed research is subject to IRB review, complete the identifying information on page 2. Include
and document the Principal Investigator(s) and Co-Investigator(s).

Project Title: Using Behavior Skills Training for Choice-Making Opportunities for Direct
Support Professionals
Date: Click here to enter a date. Mailing Address (PI):
Street: 2114 Brandeis Ave
Principal Investigator (PI) / PI: Kelly Owen
City & State: Cinnaminson, NJ
Faculty Advisor* (Advisor): Natalie Mandel
Zip Code: 08077
Faculty Advisor Institution: Rider
Email: [email protected]
Faculty Advisor Home Department:
Telephone #: (609) 781-2478
Bancroft Sponsor**: Jessica Hiller
Mailing Address #2 (Advisor):
Bancroft Sponsor Program: Street:
City & State:
Co-Investigators (If applicable): Zip Code:
1) Natalie Mandel, Ph.D, BCBA-D
Email:
2) Telephone #:

*If a doctoral student, please provide faculty sponsor above and obtain doctoral signature in Certifications section of IRB Application
**All research taking place at Bancroft requires permission from the director of the program in which the research will be conducted.
(Note: Investigators and Co-Investigators are personnel who have a role and participate in the planning, implementation and/or

Page 1 of 17
reporting functions of a research study. Investigators are responsible for the overall management of the research study, but
co-investigators can be other researchers at other worksites/performance sites, such as but not limited to a researcher at a multi-site
location or an investigator that is instrumental to and/or providing input on either the planning, implementation or reporting function
of the research. Please note that a co-investigator is different than assistants or volunteers. Please consult your faculty advisor or
contact the IRB Chair with any questions or concerns.)

Is research externally funded? ☐ Yes | ☐ No

If YES, please provide sponsor’s name:
If research is associated with a subaward, please include prime sponsor’s name:

Step 3: Determine if your research study requires a full IRB review

The Bancroft IRB handles reviews on an expedited basis (meaning that the protocol is examined by one
IRB reviewer and the chair) with the exception of those that put the participant at greater than “minimal
risk” (see below).
(Note: "Minimal risk" means that the risks of harm anticipated in the proposed research are not
greater, considering probability and magnitude, than those ordinarily encountered in daily life or during
performance of routine physical or psychological examinations or tests. The concept of risk goes beyond
physical risk and includes risks to the participant's dignity and self-respect as well as psychological,
emotional, or behavioral risk.)

Please indicate the level of risk participants will face in your research study:

☐ Greater than minimal risk OR ☐ Not greater than minimal risk

Please check one of the following:

(Note: The information below is voluntary. Researchers may identify a category below, but the IRB will provide
the final determination related to whether or not the research protocol is full, expedited or exempted.)

☐ Full Review Needed

☐ Exemption Review Needed
☐ Expedited Review Needed
☐ Expedited Review with Exemption Number ____ (See Appendix B)

Step 4: Conflict of Interest:

(NOTE: If you are submitting a Proposal Planning Form to the Office of Sponsored Program because this study is externally funded,
then do not complete the procedure below for any personnel that has submitted a conflict of interest or significant financial interest to
the Office of Sponsored Programs. However, please identify, in name, the personnel below and include any copy of a General COI
Disclosure Statement or Significant Financial Interest form submitted to the Office of Sponsored Programs as an attachment with this
application.)

Conflict of Interest is best defined as situations in which financial or other personal considerations may
compromise, or have the appearance of compromising, an investigator's judgment(s) in conducting or reporting
research

1) Does a conflict of interest(s) associated with the Principal Investigator, Co-Investigator(s) or any other
personnel involved in the research design, implementation, or reporting of this research exist?

Page 2 of 17
☐ Yes | ☐ No

(NOTE: If the study personell have any conflict, please complete the steps below.)

a) If yes, please perform the following:

a. Please list the name of the individual(s):

Step 5: Complete the following information:

PROTOCOL DESCRIPTION:
1. THE HUMAN SUBJECTS INVOLVED IN THIS RESEARCH:

a) Who are the subjects?

Participants will include direct support professionals, clinical associates, ABA associates, and
paraprofessionals.

b) Do your subjects include any of the following:

☐ Yes | ☐ No Pregnant Women or Human Fetuses or Neonates?
☐ Yes | ☐ No Children and Minors ages seven through seventeen?
☐ Yes | ☐ No Infants or Children younger than seven years of age?
☐ Yes | ☐ No Cognitively Impaired Persons?
☐ Yes | ☐ No Inmates/Prisoners?
☐ Yes | ☐ No Elderly/Aged Persons?
☐ Yes | ☐ No Non-English Speaking Persons?

NOTE: These subjects, by virtue of their age or status, may not be competent or free to give their own consent and may
be particularly vulnerable to coercion and undue influence. Investigators must incorporate additional safeguards into
the research plan and document fully the informed consent of these individuals and/or that of their legal representatives.
If excluding minors, please explain how.

How many subjects will be involved in the project? up to 5

b) Specify your plans for including women and minorities, if appropriate.

We will include anyone that meets inclusion criteria, regardless of gender or minority status.

c) List all inclusion and exclusion criteria.

inclusion criteria: regularly scheduled to work directly with clients
exclusion criteria: working under light or modified duty and unable to work with clients directly

d) Are your subjects students?

☐ Yes | ☐ No If YES, name the institution(s) in which they are enrolled:

Page 3 of 17
 e) Are there prospective subjects who, if selected for this project, would be especially vulnerable
to risk because of the procedures you will be using?
☐ Yes | ☐ No If YES, describe the process you will use to screen such subjects:

2. RECRUITMENT:
a) Specify how you will gain access to, recruit, and select your subjects.
Describe how you will incorporate the use of volunteers or individuals/titles of a group of
volunteers that will perform steps – handing out consent forms – in the research methodology.
Note: These volunteers do not / may not qualify as key personnel or co-investigators, but will perform a minor
aspect of the research.

Please specify and describe: Participants will be recruited through an email sent to the direct
support staff DL

b) Are you advertising or posting a notice for subjects and/or volunteers?

☐ Yes | ☐ No If YES, submit a copy of the advertisement or notice.

c) Will the subjects be recruited from your place of employment/assignment?

☐ Yes | ☐ No

d) Will the subjects be under your direct supervision? ex: Manager, Supervisor or Instructor?
☐ Yes | ☐ No If YES, explain how this research relates to your job role and provide any other
information pertinent to your relationship with the subjects (e.g., how will you
ensure against the possibility of coercion?):

3. COST/PAYMENT:
a) Are you paying your subjects?
☐ Yes | ☐ No If YES, indicate the amount of payment and describe if (and how) you will
pro-rate the payments to subjects who withdraw before they complete their
participation:

b) Will participation in the study involve any cost to the subject?

☐ Yes | ☐ No If YES, indicate the anticipated costs to the subject.

4. INFORMED CONSENT:
a) Does your protocol involve the use of an informed or alternate consent form?
☐ Informed Consent Form
☐ Alternate Consent Form
☐ Informed Consent and Alternate Consent Form
☐ Consent Form or Alternate Form is not being used
If using an Informed or Alternate Consent form, then please enclose a copy of the form. Informed
consent must be obtained from the subjects and/or, in the case of minors under the age of 18, the
parent or legal guardian. See Appendix B & C for instructions on informed consent. All
requirements must be met.

Page 4 of 17
 b) If using an alternate consent form or waiver, please provide the following:

Please explain how using an alternate consent form or waiving consent will not adversely affect the
rights and welfare of the subjects:

Please explain how conducting the research cannot be performed or practically carried out without
using an alternate consent form or waiving consent:

Whenever appropriate, how will the subjects be provided and informed of additional pertinent
information after participation?
Please explain:

Does the sponsor of the research or federal, state and local laws prohibit the use of an alternate
consent form or waiver of consent or require additional information to be disclosed for informed
consent to be legally effective?
☐ Yes | ☐ No

If your project will not include an informed or alternate consent form, explain how consent will be
obtained.
Please explain, if applicable:

NOTE: If the only record linking the subject and the research would be the consent document and the research
presents no more than minimal risk of harm to subjects, you may use an alternative procedure for consent. (See
Appendix B and C for more information)
b) Will the research be conducted at a site other than Bancroft?
☐ Yes | ☐ No If YES, list the institutions and provide letters from appropriate
institutional official(s) with the authority to approve research at their
institution (e.g. school principal, school superintendent, director of
institution, IRB):

5. THE RESEARCH PROCEDURES:

a) Describe in non-scientific language exactly what you will be doing to, or with, your subjects.
Include in your description:
- The goal/s of the research
- The procedures to be followed
- The role of the Co-Investigator(s) / Co-Principal Investigator(s)

Please describe: The goal of this research is to increase the number of choices that staff provide.
Procedures for this research includes a baseline phase that measures the number of choices across leisure
activities, a treatment phase where a training package of rationale, training, rehearsal, and feedback.
Generalization of the training package will be assessed across a different activity that was trained, such as
during meals and assisted daily living tasks. See attached protocol for further clarification. Data will be
collected on the number of choices provided to determine if an increase is seen from the training package.
Participants will also be asked to take a questionnaire on the social validity of the training package and if the
training is helpful for the clients and program they work in. The role of the primary investigator will be to gain

Page 5 of 17
consent, run sessions, ensure reliability data is collected, graphing the data collected and evaluating the
treatment procedure through visual analysis. The role of the co-investigator is to supervise the project.

b) Will you be carrying out procedures or asking questions that might disturb your subjects
emotionally or produce stress or anxiety?
☐ Yes | ☐ No If YES, describe your plans and criteria for counseling such subjects:

c) Are you using a questionnaire, survey, and/or an interview as part of your procedure?
☐ Yes | ☐ No If YES, submit a copy of the questionnaire(s) and/or interview questions.

d) Are you using focus group discussions as a part of your procedure?

☐ Yes | ☐ No If YES, submit a copy of the focus group guide.

e) Does your study involve deception of your subjects?

☐ Yes | ☐ No If YES, describe the deception, justify its need, and describe the procedure you
will use to debrief your subjects. Submit a copy of the debriefing
statement, which should include a statement of your willingness to allow
subjects to withdraw from your study after debriefing and to remove from
your files all records of their involvement:

f) Will this study involve the use of existing data, documents, records, pathological specimens, or
diagnostic specimens?
☐ Yes | ☐ No If YES, include authorization to access the data if not publicly available
from an official with authority to provide such permission.

6. DATA STORAGE/DISPOSITION:
a) Will participants’ names be kept:
☐ Confidential ☐ Anonymous ☐ Neither
(See Appendix B (Informed Consent) for definitions of these terms)

b) If participants’ names are to remain confidential how will confidentiality be

maintained?
Please describe: Participants name will not be entered on to data sheets or spreadsheets. Assigned
participant numbers will be used.

c) What kinds of data will you use?

Check all that apply:
☐ Paper (Hard copy)
☐ Digital (Computerized) data
☐ Audio/video recordings
☐ Lab specimens
☐ Other (please specify):

Describe how you will keep your data secure while conducting the research:
Page 6 of 17
 The paper data will be stored in a locked drawer in the office. Anything converted into graphs
will be on a password-protected computer. No written names will be anywhere on the collected data sheets.

d) Describe how you will ultimately secure, store, and dispose of your data (notes, drafts, lists of
subjects, photographic records, tapes, computer disks, flash drives, etc.) after you have completed your
research (e.g. shredding, burning) Please note that all research records must be maintained for at least
five (5) years after the completion of the research, including consent forms, flyers, etc. If you do not
plan to destroy research data, please provide a justification for maintaining the data for an
indefinite period of time and how you will ensure confidentiality:
Please describe: Once data is uploaded into a spreadsheet, all paper data sheets will be shredded after
2 years.

7. RISK/BENEFIT:
In three or four sentences, summarize the risk/benefit ratio of the proposed research, with regard
to the human subjects, the risks to them, and the potential benefits to knowledge or society:
This research will possibly benefit staff to improve the opportunities for choices provided throughout the
day. There are no significant risks to this research.
There is an inherent risk of injury when working with clients with challenging behavior, but the risk of
injury is not greater than risks associated with employment at Bancroft.

8. COLLABORATION:
Does this research project involve the IRB approval of one or more participating institutions or
organizations other than that of Bancroft?
☐ Yes | ☐ No If YES, list the institutions and submit copies of the related IRB approval notices.
Please list institutions:

Note: If conducting human subjects’ research in collaboration with another institution doing the same research,
then a Single-Study Authorization Agreement can be developed and finalized. The single-study authorization
agreement will provide authority to either the collaborator’s IRB or the Bancroft IRB to review the study and be
the IRB of record. For more information, contact Tracy Kettering, Bancroft IRB Chair, at
[email protected].

9. ADDITIONAL INFORMATION (OPTIONAL) (Attach a separate sheet if needed)

Page 7 of 17
CERTIFICATIONS:
Bancroft maintains a Federal-wide Assurance (FWA) with the Office of Human Research Protection (OHRP),
U.S. Department of Health & Human Services. This Assurance includes a requirement for all research staff
working with human participants to receive training in ethical guidelines and regulations. "Research staff" is
defined as persons who have direct and substantive involvement in proposing, performing, reviewing, or
reporting research and includes students fulfilling these roles as well as their faculty advisors. Once training is
complete with an overall score of 80 percent or higher, Collaborative Institutional Training Initiative (CITI)
certificates will generated automatically on-line to the Research Office.
To begin CITI training, go to https://www.citiprogram.org/. Click on “New User” to create an account and
choose your affiliation. Once you are logged into the system, register for Human Subjects Research Training
module in your area of expertise.

Note that if you have a current NIH certificate in Human Subjects training you may use it instead of the CITI
training until it expires (after 3 years). Otherwise, all researchers are expected to obtain a Human Subjects training
certificate from the CITI training program.

Note also that if your research is externally funded, there may be additional training requirements of which the IRB
Chair will inform you.

Principal Investigator:
I certify that I am familiar with the ethical guidelines and regulations regarding the protection of human
participants from research risks and will adhere to the policies and procedures of the Bancroft Institutional
Review Board. I will ensure that all research staff working on the proposed project, who will have direct and
substantive involvement in proposing, performing, reviewing, or reporting this research (including students
fulfilling these roles), will complete IRB approved training. I will not initiate this research project until I receive
written approval from the IRB. I agree to obtain informed consent of participants in this project if required by
the IRB; to report to the IRB any unanticipated effects on participants which become apparent during the course
or as a result of experimentation and the actions taken as a result; to cooperate with the IRB in the continuing
review of this project; to obtain prior approval from the IRB before amending or altering the scope of the
project or implementing changes in the approved consent form; and to maintain documentation of consent
forms and progress reports for a minimum of three years after completion of the final report or longer if
required by the sponsor or the institution. I further certify that I have completed training regarding human
participant research ethics within the last three years as indicated below my signature.

08/09/2024
Signature of Principal Investigator: _________________________________________ Date: __________

Please go to the next pages for the Faculty Principal Investigator, Doctoral Advisor, Bancroft Sponsor
certification statements and signature lines.

Page 8 of 17
Faculty Advisor:
I certify that I am familiar with the ethical guidelines and regulations regarding the protection of human
participants from research risks and will adhere to the policies and procedures of the Bancroft Institutional
Review Board. I will ensure that all research staff working on the proposed project, who will have direct and
substantive involvement in proposing, performing, reviewing, or reporting this research (including students
fulfilling these roles), will complete IRB approved training. I will not initiate this research project until I receive
written approval from the IRB. I agree to obtain informed consent of participants in this project if required by
the IRB; to report to the IRB any unanticipated effects on participants which become apparent during the course
or as a result of experimentation and the actions taken as a result; to cooperate with the IRB in the continuing
review of this project; to obtain prior approval from the IRB before amending or altering the scope of the
project or implementing changes in the approved consent form; and to maintain documentation of consent
forms and progress reports for a minimum of three years after completion of the final report or longer if
required by the sponsor or the institution. I further certify that I have completed training regarding human
participant research ethics within the last three years as indicated below my signature.

Signature of Faculty Advisor: _________________________________________Date: _______

Doctoral Advisor (if Researcher is a doctoral student): Is this research to fulfill your doctoral requirements?
☐ Yes | ☐ No

If YES, please list the College:

If YES, have your doctoral advisor sign the application (if the same as your faculty advisor, then the Doctoral
Advisor’s name can be printed below:
Signature of Doctoral Advisor: _________________________________________ Date: _________________

Page 9 of 17
Bancroft Sponsor:

Name: ______Jessica Hiller_____________________ Program: ___Lindens_____________________

I certify that I am the director of the program at Bancroft listed above. I certify that I am familiar with the ethical
guidelines and regulations regarding the protection of human participants from research risks and will ensure
that the policies and procedures of the Bancroft Institutional Review Board are upheld. Pending approval from
the Bancroft IRB and the continued compliance with Bancroft IRB's policies and procedures, I give permission
for this research project to be conducted on the premises of the program listed above and/or with persons served
by this program at Bancroft. I agree to monitor the data collected by this research project to ensure the safety of
the participants and I agree to report any concerns to the Bancroft IRB.

Signature of Bancroft Sponsor: _________________________________________Date: _______ ____

Page 10 of 17
Step 5: Complete the checklist below.

INVESTIGATOR CHECKLIST

DIRECTIONS: (Use NA if "not applicable")

☐ Yes | ☐ NA Application typed or computer-generated, not hand written

☐ Yes | ☐ NA Identifying information complete

☐ Yes | ☐ NA Principal Investigator's signature on application

☐ Yes | ☐ NA Names of all investigators specified

☐ Yes | ☐ NA Summary in non-technical terms

☐ Yes | ☐ NA Risks and benefits specified

☐ Yes | ☐ NA Informed Consent form appended

☐ Yes | ☐ NA All instruments appended (e.g. questionnaires, standardized tests, interview schedules)

☐ Yes | ☐ NA Advertisement for recruitment of participants appended, if relevant

☐ Yes | ☐ NA Approval letter(s) from ALL relevant off-campus site(s) (e.g. school principal, other
IRB's) appended

☐ Yes | ☐ NA If applicant is a STUDENT, advisor signature included

☐ Yes | ☐ NA Indicated that application needs “full review,” “expedited review,” or “expedited review
with exemption.”

☐ Yes | ☐ NA “Certifications” form for PI, Co-investigator/s, and Bancroft Sponsor completed and
signed

Step 6: Please send one (1) electronic copy of the completed original copy to Tracy Kettering at
[email protected]. If you have technical questions about your IRB application, you may send
an e-mail to Tracy Kettering.

END OF APPLICATION

Page 11 of 17
Appendix A: Training Certificate

Appendix B: Email Advertisement

Hello,

My name is Kelly Owen and I am an ABA Specialist at Bancroft. I am conducting research to increase choice
opportunities when working with clients. If you are interested in participating in this study, please reach out via
email at [email protected].

Thank you!
Kelly Owen

Page 12 of 17
Appendix C: Informed Consent Form

ELECTRONIC CONSENT Form

Please carefully review the information provided below regarding the study before providing consent for participation. If you have any
questions about the study, please reach out to the principal investigator, Kelly Owen, [email protected].

Study Title: Using Behavioral Skills Training for Choice-Making Opportunities for Direct Support Professionals

Study Investigators: Kelly Owen, Natalie Mandel

Study Description: The goal of the project is to determine if a specific training package is effective at teaching individuals how to
implement choice-making opportunities.

Inclusion Criteria: Currently employed at Bancroft and regularly works with direct clients within Bancroft

Exclusion Criteria: Unable to work directly with clients due to working restrictions, such as light or modified duty.

Potential Benefits: Possible benefits include research, knowledge of a variety of methods to provide choices throughout daily
activities. There are no significant risks to this study.

Potential Risks: There is an inherent risk of injury when working with clients with challenging behavior, but the risk of injury is not
greater than risks associated with employment at Bancroft.

The total duration of participation will be 3-8 weeks, including up to 15 test or training sessions and probes depending on the phase of
the study, time dedicated will consist of 15 minutes for each day when a session is occurring, for a total of approximately 4 hours over
the course of the study.

Privacy

The data will be kept secure. Records and data generated by the study may be reviewed by Bancroft’s Institutional Review Board to
assure proper conduct of the study and compliance with federal guidelines. If the data gathered during this study are published,
you/your care recipient will not be identified by name.

You may ask questions about the study at any time. We understand that you are volunteering yourself and that you may withdraw at
any time without any penalty. Questions about your rights as a research participant may be directed to Dr. Tracy Kettering, at
[email protected]

Name of Participant: __________________________________________

Today’s Date:_________________________

I have received a copy of the consent form and have had an opportunity to have all of my questions about this study answered.

YES ______ NO ______

Consent Response:

( ) I do provide consent

( ) I do not provide consent

Name of person providing consent: _____________________________________

Page 13 of 17
Appendix D: Session Protocol

Participants: Direct Support Staff

Primary Investigator: Kelly Owen
BCBA Supervisor: Natalie Mandel

Session Setting and Duration: natural environment (within a unit or outdoors) or session room; 15 minute
sessions

Resources Needed: 1-2 data collectors, activity related materials

Data Collection: frequency

Primary dependent variable: number of choice-making opportunities given

Definition: a situation in which a student or client is provided with an open-ended choice or two or more
options to choose from given what’s available in the environment.
Independent variable: BST
Definition: a 1:1 training consisting of rationale, written instructions, modeling, rehearsal, and feedback

Target Activity: leisure activities (e.g., puzzles, books, games, music, coloring, watching videos, etc )
These are activities that direct support professionals will have access to in the natural environment and can
provide throughout their work day.
Alternative Activity: selected via randomized generator for each participant, with the exception of a certain
exclusions (e.g., dietary restrictions)
Alternative Activity: meals/snacks and ADL’s

Data Collector Criteria: trained in frequency data collection for the protocol

Experimental Design: non-concurrent multiple probe across participants with alternate activity probes
Baseline Session Procedures:
● session length: 15 minutes
● move-on criteria: stable responding (minimum 1 session – maximum 3 sessions)
1. The therapist will provide the participant with written instructions that review descriptions of different
ways to offer choice-making opportunities in the targeted activity.
2. The therapist will observe the participant in their normal routine with a client during the targeted
activity.
3. No coaching or feedback will be provided for the participant during the session.
4. Participants will not continue on within treatment if a participant has 5 or more choice-making
opportunities presented within a session
Alternate Activity Probe Session Procedure:
● session length:15 minutes
● move-on criteria: 1 session.
1. The therapist will observe the participant in their normal routine with a client during the alternate
activity.
2. No coaching or feedback will be provided for the participant during the session.

Page 14 of 17
BST Session Procedures:
● session length: 15 minutes
● move-on criteria: 100% correct responding in different choice opportunities in the targeted activity (min 3 sessions)
1. The therapist will provide the participant with written instructions that review descriptions of different
ways to offer choice-making opportunities in the targeted activity.
2. The therapist will provide training on different ways to offer choice-making opportunities in the targeted
activity.
3. The therapist will provide the participant with time to ask questions about choice diversity.
4. The therapist will model to the participant a variety of ways to provide different choice-making
opportunities in the targeted activity.
5. The therapist will then rehearse different choice-making opportunities within the targeted activity with
the participant.
6. The therapist will then provide the participant time to independently role-play the different
choice-making opportunities within the targeted activity.
7. The therapist will provide feedback according to the feedback script as determined by the performance
in the role-play.
o The trainer provides positive feedback for the correct choice offering.
o The trainer provides coaching feedback for not providing a choice offering.
o The trainer reviews different types of choices for participants voicing confusion or stating
there are no choices to provide.
Post-BST Session Procedures:
● session length: 15 minutes
● move-on criteria: 100% correct responding in different choice opportunities in the targeted activity (minimum 3
sessions)
1. The therapist will provide the participant with written instructions that review descriptions of different
ways to offer choice-making opportunities in the targeted activity.
2. The participant will be told to provide 10 different choice-making opportunities with the therapist in the
targeted activity.
3. The therapist will provide feedback according to the feedback script as determined by the performance
in the role-play.
o The trainer provides positive feedback for the correct choice offering.
o The trainer provides coaching feedback for not providing a choice offering.
o The trainer reviews different types of choices for participants voicing confusion or stating
there are no choices to provide.

In-Vivo Trained Activity & Alternate Activity Probe Session Procedure:

● session length:15 minutes
● move-on criteria: 1 session.
1. The therapist will provide the participant with written instructions that review descriptions of different
ways to offer choice-making opportunities in the targeted activity.
2. The therapist will observe the participant in their normal routine with a client during the trained &
alternate activity.
3. No coaching or feedback will be provided for the participant during the session.
o If at any time the participant falls below the baseline level of offering choice-making
opportunities, a booster BST session will be given to the participant.

Page 15 of 17
Follow-Up Session Procedures:
● session length: 15 minutes
● move-on criteria: 1 session.
1. The therapist will provide the participant with written instructions that review descriptions of different
ways to offer choice-making opportunities in the targeted activity.
2. The therapist will observe the participant in their normal routine with a client during the targeted and
alternate activity.
3. No coaching or feedback will be provided for the participant during the sessions.

Appendix E: Data Collection Sheet

Page 16 of 17
Appendix F: Social Validity Questionnaire

Page 17 of 17